Whole-Body Diffusion-Weighted MRI for Detection of Bone Metastases in mRCC Patients Treated With Angiogenesis Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Whole-Body Diffusion-Weighted Magnetic Resonance Imaging for the Detection of Bone Metastases and Their Prognostic Impact in Metastatic Renal Cell Carcinoma Patients Treated With Angiogenesis Inhibitors
Acta Oncol 2020 Apr 16;[EPub Ahead of Print], B Beuselinck, S Pans, J Bielen, L De Wever, N Noppe, G Vanderschueren, F De Keyzer, M Baldewijns, E Lerut, A Laenen, A Verbiest, E Roussel, M Albersen, V VandecaveyeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.